Traditional Chinese medicine composition with visual function protection effect as well as preparation method and application of traditional Chinese medicine composition

The preparation of traditional Chinese medicine compositions by combining wolfberry and chrysanthemum extracts has solved the problem of single ingredients and side effects of existing eye drops, effectively relieve visual fatigue and visual function protection, and significantly improve retinal damage and inflammatory response. It has safe and efficient visual function protection effect.

CN119033862APending Publication Date: 2024-11-29NANJING UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411209520.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing eye drops have problems such as single ingredients, small coverage, and prone to side effects in the treatment of visual fatigue, and cannot effectively protect visual function.

Method used

A traditional Chinese medicine composition consisting of wolfberry and chrysanthemum extract was developed. Through specific extraction and preparation methods, a compound product of wolfberry polysaccharide, wolfberry pigment, chrysanthemum acid and flavonoids was prepared for visual function protection.

Benefits of technology

This composition significantly improves retinal damage, reduces oxidative stress and inflammatory response, has good visual function protection, is suitable for alleviating visual fatigue and protecting vision, and is safe and has no obvious toxic side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119033862A_ABST
    Figure CN119033862A_ABST
Patent Text Reader

Abstract

The invention discloses a composition with a visual function protection effect as well as a preparation method and application thereof. The composition is prepared from active extracts in medicinal and edible traditional Chinese medicines of fructus lycii and chrysanthemum, wherein the active extracts comprise lycium barbarum polysaccharide, lycium barbarum pigment, chrysanthemum phenolic acid and flavone. The composition provided by the invention can effectively improve asthenopia symptoms and protect eyesight. The traditional Chinese medicine composition provides a thought for development and utilization of medicinal and edible traditional Chinese medicine resources and research and development of health products for eyesight protection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and relates to a natural product composition, in particular to a traditional Chinese medicine composition with visual function protection effect, and a preparation method and application thereof. Background Art

[0002] Eyes are one of the most sensitive and important sensory organs of the human body. Their health is directly related to people's quality of life and work efficiency. In recent years, with the continuous improvement of the information society, mobile phones, computers and other electronic devices have become increasingly popular, which has led to an increase in people's close-up and fine use of their eyes. Eye health problems such as visual fatigue have become increasingly prominent. Relieving visual fatigue and protecting eyesight have become important issues that we cannot ignore.

[0003] The emergence of video display terminals has brought many conveniences to people's daily work, study and life, but at the same time, it has also caused people to use their eyes more and more closely, resulting in serious visual overload, blurred vision, dry eyes, tearing and photophobia, and even headaches and dizziness. We call this type of symptom computer vision syndrome (CVS). If CVS is not relieved for a long time, it will increase visual fatigue, cause dry eyes, myopia, conjunctivitis and other eye problems, and affect people's physical and mental health and quality of life. Therefore, it is of great significance to develop safe and effective drugs to relieve visual fatigue and protect vision health.

[0004] The eye is a very delicate organ of the human body. Modern medicine believes that the decline in visual function is mainly related to the damage of the fundus and eye cell function and the loss of nutrients in eye cells. The fundus refers to the tissue structure in the back of the eyeball, including the retina, optic nerve, optic chiasm, macula, choroid, retinal artery and vein, retinal pigment, etc. The damage of fundus function is mainly related to fundus oxidative stress damage, inflammatory damage, cell aging and excessive loss of retinal photoreceptor cells. The ocular surface refers to the tissue structure on the surface of the eyeball, including the cornea and conjunctiva. The damage of ocular surface function is mainly related to the damage of the cornea and the tear film on its surface, the decline of the function of the lens or ciliary muscle and the degeneration of the eye muscle function. "Shenzhen Yaohan" records: "The eye is the essence of the five internal organs and six bowels, which is injected into the eyes for vision." The "Five Wheel Theory" in the theory of traditional Chinese medicine ophthalmology believes that the five wheels of the eye correspond to the five internal organs of the body; the meat wheel refers to the eyelid, corresponding to the spleen; the blood wheel refers to the two canthi, corresponding to the heart; the qi wheel refers to the white eye, corresponding to the lung; the wind wheel refers to the black eye, corresponding to the liver; the water wheel refers to the pupil, corresponding to the kidney. Traditional medicine believes that visual fatigue is mainly related to the dysfunction of the liver, kidney, spleen and other organs. The liver opens up to the eyes and stores blood. When discussing the etiology and pathogenesis of eye diseases, doctors of all dynasties first considered the liver. The liver is connected to the eyes through the meridians and provides the eyes with necessary nutrients. If the liver blood is sufficient and the liver qi is smooth, the eyes will be nourished and the vision will be clear; if the liver qi is insufficient and the essence and blood are damaged, the eyes will not be nourished and the vision will be unclear. The kidney is the foundation of the innate nature, storing the essence and blood of the human body. It is the organ of strength and has the function of regulating the balance of water in the body. The kidney corresponds to the water wheel among the five wheels, which controls the pupil spirit and can provide the eyes with water and other nutrients, nourish the eyeballs, and nourish the pupil spirit. The spleen and stomach are located in the middle jiao and are responsible for transportation and transformation, transporting and transforming the essence of water and grain and water. "The spleen is the head of all yin, and the eyes are the head of blood vessels." The spleen and stomach transport fine nutrients to the eyes to nourish them. "If the spleen is weak, the essence of the five internal organs will lose their functions and cannot be returned to the eyes." If the spleen is weak, the spleen fails to function properly, and the clear yang does not rise, the eyes will lose their nourishment and become cloudy. "The heart is the master of the five internal organs and six bowels," and "the heart controls the blood vessels." The heart can regulate the functional activities of the internal organs of the whole body. The eyes are nourished by the heart blood and become clearer and brighter. At the same time, the biochemistry of heart blood is inseparable from the transportation of the spleen and stomach. Only when the spleen is healthy can the heart blood be full. If you look tired and the heart and spleen are deficient, the blood will not flow smoothly, the eyes will lose their nourishment, black spots will gradually appear, and the divine light will be exhausted.

[0005] At present, Western medicine mostly uses drugs to treat visual fatigue. Eye drops are commonly used drugs to relieve visual fatigue in clinical practice, including those that reduce intraocular pressure, anti-allergic, relieve ciliary muscle fatigue, and relieve dry eyes. However, many eye drops have a single ingredient and a small symptom coverage. In addition, antibiotics and other ingredients are added to eye drops, which are prone to side effects when used for a long time, and only treat the symptoms but not the root cause. Traditional Chinese medicine has the characteristics of multiple ingredients, multiple targets, and prevention of disease, especially traditional Chinese medicine with the same origin of medicine and food. The raw materials are natural and healthy, and long-term use has no toxic side effects. It has unique advantages in relieving visual fatigue, protecting eyesight, and enhancing human immunity. Therefore, making full use of my country's traditional Chinese medicine resources to develop safe and effective visual function protection products has a good development prospect. Lycium barbarum and chrysanthemum are both traditional Chinese medicines with the same origin of medicine and food. Ancient books such as "Taiping Huimin Hejiju Fang", "Shengji Zonglu", "Puji Fang", and "Jiyan Liangfang" record that the two are often used in combination to treat eye diseases such as dim eyes, liver and kidney deficiency, and unclear vision. Lycium barbarum is a yin-tonifying medicine, with a sweet taste and a mild nature, and it belongs to the liver and kidney meridians. "Compendium of Materia Medica" records: "Lycium barbarum is moist and nourishing, and can also reduce fever, and is specialized in nourishing the kidney, moistening the lungs, promoting fluid production, and replenishing qi. It is an essential medicine for replenishing the liver and kidney true yang deficiency, fatigue and internal heat." Lycium barbarum is red in color and moist in quality. It is good at replenishing yin and strengthening water, nourishing water and containing wood. It is a product for nourishing the liver and kidney, and Chongdu essence and blood. Chrysanthemum is a wind-heat dispersing medicine, with a sweet and bitter taste and a slightly cold nature. It belongs to the lung and liver meridians. "Leigong Paoyaoxingjie" proposes that chrysanthemum can enter the liver, kidney, lung, and spleen meridians to treat diseases of the head, skin, heart and chest, and can also replenish yin qi, improve hearing and eyesight. Chrysanthemum is light and fragrant, sweet and moist, bitter and laxative, and enters the gold and water yang division, which can dissipate wind and heat, clear the liver and improve eyesight, and suppress liver yang. Lycium barbarum is mainly used for nourishment, while chrysanthemum is mainly used for clearing. The two are used together, one for nourishment and one for clearing, and they can benefit the liver and improve eyesight. Modern pharmacological studies have shown that wolfberry polysaccharides, carotenoids and other ingredients in wolfberry have pharmacological activities such as anti-oxidative stress, anti-aging, anti-inflammatory, neuroprotection, and vision protection. Flavonoids and phenolic acid components in chrysanthemum are natural antioxidants with pharmacological effects such as free radical scavenging, anti-inflammatory, and antibacterial. Therefore, it is necessary to develop a wolfberry and chrysanthemum composition and its extraction and preparation method to provide new products and technical support for the field of functional foods and drugs. Summary of the invention

[0006] Purpose of the invention: The purpose of the present invention is to provide a Chinese medicine composition with reliable efficacy, good safety and good visual function protection effect, the Chinese medicine composition is compounded with extracts of wolfberry and chrysanthemum. Another purpose of the present invention is to provide a preparation method and application of the above Chinese medicine composition.

[0007] Technical solution: In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0008] A Chinese medicine composition with a visual function protecting effect, characterized in that it comprises the following Chinese medicine raw materials in parts by weight: 2.5 to 7.5 parts of wolfberry and 2.5 to 7.5 parts of chrysanthemum.

[0009] As a preferred embodiment, the above-mentioned Chinese medicine composition with visual function protection effect is characterized in that it comprises the following Chinese medicine raw materials in parts by weight: 2.5 to 5 parts of wolfberry and 5 to 7.5 parts of chrysanthemum.

[0010] As a particularly preferred embodiment, the above-mentioned Chinese medicine composition with visual function protection effect is characterized in that it comprises the following Chinese medicine raw materials in parts by weight: 5 parts of wolfberry and 5 parts of chrysanthemum.

[0011] A composition with a visual function protection effect, characterized in that the weight ratio of wolfberry polysaccharide, wolfberry pigment, chrysanthemum phenolic acid and flavonoids is 7.5:1.35:4.5.

[0012] As a preferred embodiment, the above-mentioned composition is characterized in that the wolfberry polysaccharide, wolfberry pigment, chrysanthemum phenolic acid and flavonoids are prepared by the following steps respectively:

[0013] (1) Preparation of Lycium barbarum polysaccharide: Take dried Lycium barbarum medicinal material, add distilled water, heat and reflux to extract, concentrate the extract, dry and grind to obtain;

[0014] (2) Preparation of wolfberry pigment: extract the wolfberry fruit with water and dry the residue, add an organic solvent to extract, concentrate the extract, and dry it to obtain the pigment;

[0015] (3) Preparation of chrysanthemum phenolic acid and flavonoids: Take dried chrysanthemum medicinal materials, add extraction solvent, heat reflux extraction, concentrate the extract, purify, dry and grind to obtain the flavonoids.

[0016] The preparation method of the above-mentioned composition comprises the following steps:

[0017] (1) When extracting Lycium barbarum polysaccharide, add 12 times the amount of distilled water, heat and reflux for extraction 3 times, the first two times for 90 minutes, the third time for 60 minutes, keep the residue for later use, concentrate the extract under reduced pressure, add ethanol to the concentrate until the alcohol concentration is 80%, low temperature alcohol precipitation for 24 hours, collect the precipitate, and dry it with hot air at 80°C;

[0018] (2) When extracting wolfberry pigment, add 8 times the amount of organic solvent for extraction, soak in a water bath at 45°C for 3 times, each time for 90 min, and cool and reduce the pressure of the extract to recover the solvent;

[0019] (3) When preparing chrysanthemum phenolic acid and flavonoids, 20 times 60% ethanol was added for the first extraction for 120 minutes, and 15 times 60% ethanol was added for the second and third extractions for 90 minutes. The extract was concentrated under reduced pressure to 0.8 g / mL and purified by AB-8 macroporous resin column. The chrysanthemum concentrate was adsorbed for 2 hours, and impurities were washed away with 5BV of distilled water. Then, 6BV of 70% ethanol was used for elution. The 70% ethanol eluate was collected and concentrated.

[0020] Beneficial effect description: The Chinese medicine composition provided by the present invention, which is compounded with wolfberry and chrysanthemum extracts, is obtained by consulting a large number of literature screening. And the results of animal model experiments show that the Chinese medicine composition provided by the present invention can effectively improve retinal damage such as retinal thinning and disordered arrangement of retinal layers, reduce oxidative stress and inflammatory response in mice and eyeball tissues, and has a certain protective effect on vision. The above studies show that the Chinese medicine composition provided by the present invention has a significant improvement effect on retinal damage, can be used to prepare medicines, health foods or special functional foods with visual function protection and relief of visual fatigue, and is suitable for people with excessive eye use, eye fatigue, and vision loss.

[0021] The Chinese medicine composition with visual function protection effect described in the present invention is used in the preparation of visual function protection products and medicines. The extract is compounded with a pharmaceutically acceptable carrier to prepare the medicine in the form of tablets, pills, powders, granules, microcapsules, etc., which is convenient for clinical use. In addition, the Chinese medicine composition provided by the present invention has no obvious toxic and side effects found during the experiment and has good safety. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a graph showing the effect of the Chinese herbal medicine composition on the proportion of time mice spend active in the white box.

[0023] Figure 2 This is a graph showing the effect of the Chinese medicine composition on the fundus condition and average retinal thickness of mice.

[0024] Figure 3 This is the result of HE staining of mouse retinal tissue by the Chinese medicine composition.

[0025] Figure 4 It is a bar graph showing the effect of the Chinese medicine composition on the levels of SOD, GSH and MDA in mouse serum.

[0026] Figure 5 It is a bar graph showing the effect of the Chinese medicine composition on the contents of SOD, GSH and MDA in the eyeball tissue of mice.

[0027] Figure 6 It is a bar graph showing the effect of the Chinese medicine composition on the levels of TNF-α, IL-1β, and IL-6 in mouse serum.

[0028] Figure 7 It is a bar graph showing the effect of the Chinese medicine composition on the contents of TNF-α, IL-1β and IL-6 in the eyeball tissue of mice. DETAILED DESCRIPTION

[0029] The present invention is further explained below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. After reading the present invention, various equivalent modifications of the present invention by those skilled in the art all fall within the scope defined by the claims attached to this application.

[0030] Embodiment 1 The preparation method of wolfberry extract (lycium barbarum polysaccharide) comprises the following steps:

[0031] (1) Weigh the dried wolfberry fruit and place it in a round-bottom flask. Add 12 times the weight of the fruit and reflux it under heating. Boil it over high heat. Start timing when the liquid boils and drops of liquid reflux. Adjust the temperature to keep the extract at a slight boiling point. Extract three times, 90 min for the first two times and 60 min for the third time. Combine the extracts.

[0032] (2) The extract is concentrated under reduced pressure, and ethanol is added to the concentrate to a concentration of 80%, and low-temperature alcohol precipitation is performed for 24 hours. The precipitate is collected, dried with hot air at 80° C., and crushed to obtain Lycium barbarum polysaccharide.

[0033] Embodiment 2 The preparation method of wolfberry extract (wolfberry pigment) comprises the following steps:

[0034] (1) Weigh the dried wolfberry residue, put it into a conical flask, add 8 times the weight of the residue and extract with an organic solvent, heat at 45°C, extract for 3 times, each time for 90 min, and combine the extracts.

[0035] (2) The extract is subjected to low temperature and reduced pressure to recover the solvent and dry to obtain wolfberry pigment.

[0036] Example 3 A method for preparing a chrysanthemum extract (chrysanthemum phenolic acid and flavonoids), comprising the following steps:

[0037] (1) Weigh the dried chrysanthemum medicinal material and put it into a round-bottom flask. Add 20 times 60% ethanol for the first time and heat under reflux to extract for 120 minutes. Add 15 times 60% ethanol for the second and third times and extract for 90 minutes. Filter with gauze and combine the extracts.

[0038] (2) The extract is concentrated under reduced pressure to 0.8 g / mL, and ethanol is recovered to obtain a chrysanthemum extract concentrate.

[0039] (3) The macroporous resin column separation method was used to purify the chrysanthemum phenolic acid and flavonoids. AB-8 resin was used and wet-packed on the column. The resin was first rinsed with distilled water to compact the resin. Then 10 mL of 0.8 g / mL chrysanthemum extract was taken and adsorbed for 2 h. Impurities were washed with 5 BV of distilled water and then eluted with 6 BV of 70% ethanol. The 70% ethanol eluate was collected, concentrated, dried, and crushed to obtain chrysanthemum phenolic acid and flavonoids.

[0040] Example 4 A method for preparing an active ingredient composition having a visual function protecting effect comprises the following steps:

[0041] The wolfberry polysaccharide, wolfberry pigment, chrysanthemum phenolic acid and flavonoid components prepared in Example 1-3 were used to form an active ingredient composition in a weight ratio of 7.5:1.35:4.5.

[0042] Example 5 Experimental study on the protective effect of Chinese medicine composition on visual function

[0043] 1. Experimental Materials and Drugs

[0044] 1. Drugs and Reagents

[0045] Lycium barbarum (batch number: 2111255) was purchased from Ningxia Mingde Chinese Medicine Pieces Co., Ltd., and chrysanthemum was picked in Yangma Town, Sheyang County, Yancheng City, Jiangsu Province in October 2022. Professor Duan Jinli of Nanjing University of Chinese Medicine identified them as the dried mature fruits of Lycium barbarum L., a plant of the Solanaceae family, and the dried capitula of Chrysanthemum morifolium Ramat., a plant of the Asteraceae family. AREDS2 [Bausch Lomb, batch number: 2807HV365]; sodium iodate (Shanghai McLean Biochemical Technology Co., Ltd., batch number: C11815462, purity: 99%); compound tropicamide eye drops (Changchun Dirui Pharmaceutical Co., Ltd., national medicine standard H20103127); ulanose (Shanghai Yuanye Biotechnology Co., Ltd., batch number: A21IS213375, purity: 98%); sodium chloride injection (Chenxin Pharmaceutical Co., Ltd., batch number: E23022021); glacial acetic acid (Sinopharm Chemical Reagent Co., Ltd., batch number: 20230206); anhydrous ethanol (Sinopharm Chemical Reagent Co., Ltd., batch number: 20221117); xylene (Sinopharm Chemical Reagent Co., Ltd., batch number: 10023418); eyeball fixative (Beijing Regen Biotechnology Co., Ltd., product number: DF0220). Hematoxylin-eosin (HE) staining solution set (Wuhan Servicebio Company, product number G1003); environmentally friendly dewaxing solution (Wuhan Servicebio Company, product number G1128); neutral gum (Sinopharm Chemical Reagent Co., Ltd., batch number: 10004160); BCA protein concentration assay kit (enhanced) (Shanghai Biyuntian Biotechnology Co., Ltd., product batch number: P0010); total superoxide dismutase (SOD) assay kit, malondialdehyde (MDA) assay kit, reduced glutathione (GSH) assay kit, purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.; mouse tumor necrosis factor α (TNF-α), mouse interleukin 6 (IL-6), and mouse interleukin 1β (IL-1β) were purchased from Hunan Aifang Biotechnology Co., Ltd.

[0046] 2. Experimental Instruments

[0047] JY96-ⅡN ultrasonic disruptor (Ningbo Xinzhi Biotechnology Co., Ltd.); BWS-10 constant temperature water bath (Shanghai II Yiheng Scientific Instrument Co., Ltd.); Tissuelyer-48 fully automatic sample rapid grinding instrument (Shanghai Jingxin Industrial Development Co., Ltd.); AllegraX-12R low temperature centrifuge (Beckman Coulter, USA); BT323S electronic balance (Sartorius Scientific Instrument Co., Ltd., Germany); PerkinElmer microplate reader (Molecular Devices, USA); Spectralis OCT laser ophthalmology diagnostic instrument (Heidelberg, Germany); JB-P5 embedding machine (Wuhan Junjie Electronics Co., Ltd.); RM2016 pathology slicer (Shanghai Leica Instrument Co., Ltd.); TS100 constant temperature oscillating metal bath (Shanghai Jingxin Industrial Development Co., Ltd.); ST60-4 microplate constant temperature oscillator (Thermo); AXIO Vert.A1 fluorescence inverted microscope (Zeiss); Nikon Eclipse E100 upright optical microscope (Nikon, Japan); ChemiDoc XRS+ImagingSystem gel electrophoresis imaging system (BIO-RAD).

[0048] 3. Experimental Animals

[0049] 6-8 weeks old SPF male ICR mice, weighing 25±2g, were purchased from Hangzhou Medical College, Zhejiang Province, with the experimental animal license number: SCXK(Zhejiang)2019-0002. The experimental animals were kept in the Experimental Animal Center of Nanjing University of Chinese Medicine, with room temperature maintained at 22-25°C, relative humidity at 40%-60%, light cycle at 12h, and free access to food and water. All animal experimental protocols were reviewed and approved by the Animal Experiment Ethics Committee of Nanjing University of Chinese Medicine, with approval number: 202211A013.

[0050] 2. Experimental Methods

[0051] 1. Model establishment and drug administration

[0052] After the mice were fed adaptively, 35 mg / kg of sodium iodate solution was injected into the blank group mice, and the blank group mice were injected with the same dose of normal saline solution, once a day, and the injection cycle was 7 days. After 7 days of adaptive feeding of mice, they were randomly divided into groups according to body weight, 10 in each group, i.e., blank group, model group, positive drug group, low-dose group of active ingredient composition prepared in Example 4 (crude drug 1.517 g / kg), and high-dose group of active ingredient composition (crude drug 3.034 g / kg). After the modeling was completed, the positive drug and each administration group mice were gavaged with the corresponding liquid, and the blank group and model group mice were gavaged with equal amounts of normal saline. Gavage once a day, and the gavage cycle was 15 days.

[0053] 2. Efficacy evaluation index

[0054] After the mice were given the drug, the double-door black and white box experiment was used to evaluate the visual function of the mice. The activity time of the mice in the white box within 5 minutes was recorded, and the proportion of activity time of each group of mice in the white box was calculated (%). After the mice were anesthetized, compound tropicamide eye drops were used to dilate the pupil for 5 minutes. After the pupil was dilated, corneal contact lenses were worn for fundus photography and OCT detection. The retinal morphology was observed through fundus pictures, and the total retinal thickness of the mice was measured using Image J software. After the fundus of the mice was examined by OCT, ophthalmic forceps were used to dissect and obtain the eyeball tissue. The eyeball was fixed with fixative for 24 hours, dehydrated and paraffin-embedded after fixation, and HE staining was performed. The retinal morphology was observed under an optical microscope. After the OCT detection of the mice, blood was collected from the peripheral vein of the eye, collected in a centrifuge tube, and left to stand at room temperature for 2 hours, 3500r·min -1 , centrifuged at 4℃ for 10min, serum separated, and stored at -80℃ for later use. After the mice were killed, the eyeballs were separated, blood was washed with saline, dried with filter paper, weighed, 9 times saline was added, and ground into 10% eyeball tissue homogenate. The homogenate was kept at 4℃, 3500r·min -1 The cells were centrifuged for 10 min and the supernatant was taken for testing. The contents of related factors in serum and eyeball tissue homogenate were determined according to the instructions of SOD, GSH and MDA kits, and the contents of TNF-α, IL-6 and IL-1β were detected by enzyme-linked immunosorbent assay (ELISA).

[0055] 3. Statistical processing methods

[0056] SPSS 19.0 statistical software was used for analysis. The data were compared among the groups using one-way ANOVA, and P < 0.05 indicated statistically significant differences.

[0057] 3. Experimental Results

[0058] 1. Black and white box experiment for mice

[0059] The proportion of activity time of each group of mice in the white box is shown in Figure 1 Compared with the blank group, the activity time of the mice in the model group in the white box was significantly increased; compared with the model group, the activity time of the mice in the active ingredient combination administration group in the white box was reduced.

[0060] 2. OCT examination and HE staining results

[0061] The fundus conditions and average retinal thickness of each group of mice are shown in Figure 2 Compared with the blank group, the retinal thickness of the model group was significantly thinner, multiple scars were visible in the fundus, and the fundus blood vessels were unclear; compared with the model group, the retina of the active ingredient combination group was thicker. Figure 3 , the retinal structure of the blank group mice is intact, and the inner limiting membrane, nerve fiber layer, ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), rod and cone cell layer (P), retinal pigment epithelium (RPE) can be seen from the inside to the outside, and each layer is closely arranged, with clear boundaries, uniform thickness, and normal cell morphology; the retina of the model group is uneven in thickness, with unclear boundaries of each layer, irregular arrangement of cells in the ganglion cell layer, inner nuclear layer, and outer nuclear layer, widening of intercellular gaps, disappearance of rod and cone cell layers, and rare cell necrosis. After the active ingredient composition is given, the disordered arrangement of each layer of the retina is improved to a certain extent, and the cells are arranged more closely. It is suggested that the active ingredient composition provided by the present invention has a certain improvement effect on retinal damage.

[0062] 3. Results of determination of oxidative factors in mouse serum and eyeball tissue

[0063] The results of the determination of oxidative factors in mouse serum are shown in Figure 4 Compared with the blank group, the levels of SOD and GSH in the model group were significantly reduced, and the content of MDA was significantly increased. After administration of the active ingredient composition, the levels of SOD and GSH in the serum of mice were increased, and the content of MDA was decreased, which was equivalent to the positive drug AREDS2. The results of the determination of oxidative factors in the eye tissue of mice are shown in Figure 5 Compared with the blank group, the levels of SOD and GSH in the model group were significantly reduced, and the content of MDA was significantly increased. Compared with the model group, both the AREDS 2 group and the active ingredient combination group could correct the changes of oxidative factors in the eye tissue of mice induced by sodium iodate. This shows that the active ingredient combination provided by the present invention has a good antioxidant effect.

[0064] 4. Determination of inflammatory factors in mouse serum and eye tissue

[0065] The results of the determination of inflammatory factors in mouse serum are shown in Figure 6Compared with the blank group, the levels of TNF-α, IL-1β, and IL-6 in the model group mice were significantly increased. Compared with the model group, the levels of TNF-α, IL-1β, and IL-6 in the serum of mice given the active ingredient composition were significantly reduced. The results of the determination of inflammatory factors in the eyeball tissue of mice are shown in Figure 7 Compared with the blank group, the levels of TNF-α, IL-1β, and IL-6 in the model group mice were significantly increased. Compared with the model group, the levels of TNF-α, IL-1β, and IL-6 in the eyeball tissue of mice given the active ingredient composition were significantly reduced. This shows that the active ingredient composition provided by the present invention can effectively reduce the expression of inflammatory factors in the body and eyeball tissue of mice, and has a good anti-inflammatory effect.

[0066] The above experimental results show that the active ingredient composition provided by the present invention has the effects of anti-oxidative stress, anti-inflammation, improving retinal damage, protecting eyesight, and relieving visual fatigue. Its raw materials are natural, healthy, safe and effective, and have high product development value such as medicines.

[0067] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition having a visual function protective effect, characterized in that: The invention comprises the following Chinese medicinal raw materials in parts by weight: 2.5 to 7.5 parts of wolfberry and 2.5 to 7.5 parts of chrysanthemum.

2. The Chinese medicine composition having a visual function protecting effect according to claim 1, characterized in that: The invention comprises the following Chinese medicinal raw materials in parts by weight: 5 parts of wolfberry and 5 parts of chrysanthemum.

3. A composition having a visual function protective effect, characterized in that: The weight ratio of wolfberry polysaccharides, wolfberry pigments, chrysanthemum phenolic acid and flavonoids is 7.5:1.35:4.

5.

4. The composition according to claim 3, characterized in that Lycium barbarum polysaccharide, Lycium barbarum pigment, chrysanthemum phenolic acid and flavonoids are prepared by the following steps respectively: (1) Preparation of Lycium barbarum polysaccharide: Take dried Lycium barbarum medicinal material, add distilled water, heat and reflux to extract, concentrate the extract, dry and grind to obtain; (2) Preparation of wolfberry pigment: extract the wolfberry fruit with water and dry the residue, add an organic solvent to extract, concentrate the extract, and dry it to obtain the pigment; (3) Preparation of chrysanthemum phenolic acid and flavonoids: Take dried chrysanthemum medicinal materials, add extraction solvent, heat reflux extraction, concentrate the extract, purify, dry and grind to obtain the flavonoids.

5. The method for preparing the composition according to claim 4, characterized in that: The following steps are involved: (1) When extracting Lycium barbarum polysaccharide, add 12 times the amount of distilled water, heat and reflux for extraction 3 times, the first two times for 90 minutes, the third time for 60 minutes, keep the residue for later use, concentrate the extract under reduced pressure, add ethanol to the concentrate until the alcohol concentration is 80%, low temperature alcohol precipitation for 24 hours, collect the precipitate, and dry it with hot air at 80°C; (2) When extracting wolfberry pigment, add 8 times the amount of organic solvent for extraction, soak in a water bath at 45°C for 3 times, each time for 90 min, and cool and reduce the pressure of the extract to recover the solvent; (3) When preparing chrysanthemum phenolic acid and flavonoids, 20 times 60% ethanol was added for the first extraction for 120 minutes, and 15 times 60% ethanol was added for the second and third extractions for 90 minutes. The extract was concentrated under reduced pressure to 0.8 g / mL and purified by AB-8 macroporous resin column. The chrysanthemum concentrate was adsorbed for 2 hours, and impurities were washed away with 5BV of distilled water. Then, 6BV of 70% ethanol was used for elution. The 70% ethanol eluate was collected and concentrated.

6. Use of the Chinese medicine composition according to claim 1 or 2 in the preparation of medicines for protecting eyesight and relieving visual fatigue, health foods and special functional foods.

7. Use of the composition according to claim 3 or 4 in the preparation of drugs for protecting eyesight and relieving visual fatigue, health foods and special functional foods.

8. Use of the Chinese medicine composition according to any one of claims 1 or 2 in the preparation of immune-regulating, anti-oxidative stress, anti-inflammatory drugs, health foods and special functional foods.

9. Use of the Chinese medicine composition according to any one of claims 3 or 4 in the preparation of immune-regulating, anti-oxidative stress, anti-inflammatory drugs, health foods and special functional foods.

10. According to the use of claim 8 or 9, the Chinese medicine composition or the extract composition and a pharmaceutically acceptable carrier are made into tablets, pills, powders, decoctions, granules, decoctions or extracts.

Citation Information

Patent Citations

  • Traditional prescription for treating failing eyesight

    CN104666609A

  • Chinese wolfberry fruit chrysanthemum beverage and preparation method thereof

    CN112293625A